查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1734896

2032 年脑植入市场预测：按产品、应用、最终用户和地区进行的全球分析

Brain Implants Market Forecasts to 2032 - Global Analysis By Product, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球脑植入市场预计在 2025 年达到 74 亿美元，到 2032 年将达到 162.6 亿美元，预测期内的复合年增长率为 11.9%。

被称为脑植入的先进医疗设备直接植入大脑，以促进与神经组织的沟通。这些植入具有广泛的治疗、诊断和增强应用。植入透过电极发送和接收电讯号来捕捉或诱发大脑活动。材料科学、无线技术和机器学习的最新进展大大提高了脑植入的安全性、功能性和潜在应用。

根据美国神经外科医师协会 (AANS) 的数据，肌张力不全症是一种以不自主肌肉收缩为特征的神经运动障碍，影响着美国约 25 万人。

神经系统疾病盛行率不断上升

在全球范围内，神经系统疾病的发生率正以惊人的速度成长。全球数百万人饱受癫痫、帕金森氏症、阿兹海默症、慢性疼痛和忧郁症等顽固性疾病的折磨。例如，世界卫生组织 (WHO) 估计，全球有超过 5,000 万人患有癫痫。脑植入透过控制异常神经元活动并提高患者的生活质量，提供了一种有效的干预措施。此外，由于常规治疗常常失败，尤其是在患者出现抗药性的情况下，对植入式神经刺激设备的需求也日益增长。

昂贵的手术和设备

深部脑部刺激 (DBS) 系统和其他脑植入价格昂贵，每位患者的费用在 3.5 万美元至 5 万美元之间，这还不包括手术和术后费用。高昂的初始成本和持续成本是推广此类疗法的一大障碍，尤其是在中低收入国家。即使在已开发国家，保险覆盖范围也可能有限，这阻碍了患者选择此类治疗。此外，这些成本也会对医疗保健系统产生影响，尤其是在考虑长期监测、设备维护以及可能需要调整的潜在问题时。

脑机介面（BCI）的发展

脑机介面 (BCI) 将大脑植入与外部运算系统相集成，为医疗保健和其他领域开闢了革命性的可能性。借助 BCI，截肢者或瘫痪者可以利用神经讯号操作电脑、轮椅或义肢。 Syncron 的血管内 BCI 和马斯克的 Neuralink 等计画正在吸引人们的关注，并吸引资金用于治疗和非医疗用途。此外，随着这些技术的发展及其在通讯、游戏、智慧设备和增强认知等领域的商业化部署，脑植入市场可能会显着扩展到传统医疗领域之外。

道德抵制和公众怀疑

儘管技术潜力巨大，但由于伦理和哲学方面的问题，大众仍然对脑植入持怀疑态度。倡导团体和病人可能难以接受一个人被精神控制、失去自主权并经历人格改变。在那些因宗教或文化原因而高度重视人脑神圣性的社会中，侵入性手术往往会遭到抵制。此外，随着脑植入开始混淆增强功能和治疗功能，关于伦理界线和潜在滥用的争论日益增多，导致一些市场对其实施限製或禁令。

COVID-19的影响：

新冠疫情对脑植入市场造成了多方面的影响。初期市场波动包括：由于供应链中断、医院容量减少、择期神经外科手术延后，植入手术和临床试验数量暂时下降。然而，随着医疗系统转向尖端的远端病患监控和慢性病管理解决方案，疫情也加速了对神经技术和数位医疗的投资。此外，脑雾、中风和认知障碍等长期新冠相关神经系统併发症的盛行率上升，预计也将推动市场长期成长。

深层脑部刺激器(DBS) 市场预计将成为预测期内最大的市场

预计深层脑部刺激器(DBS) 领域将在预测期内占据最大的市场占有率。 DBS 是最广泛使用的神经调节疗法，因为它在临床上取得了成功，并广泛应用于治疗帕金森氏症、自发性震颤、肌张力不全症和强迫性精神官能症。该治疗方法透过在特定脑区植入电极并传递受控电脉衝，有效地调节异常神经活动。此外，它已获得 FDA已通过核准，技术成熟，并有大量临床数据支持。此外，设备小型化、电池寿命和 MRI 相容性的技术创新正在推动其普及。

预估预测期内忧郁症领域复合年增长率最高

由于神经调节疗法的接受度不断提高以及抗治疗性忧郁症（TRD）的盛行率不断上升，忧郁症领域预计将在预测期内实现最高成长率。深部脑部刺激（DBS）和迷走神经刺激（VNS）正成为传统抗忧郁症的有效治疗方法。正在进行的临床试验以及用于情绪调节的封闭回路型系统的开发，增加了人们对植入式解决方案的兴趣。此外，新冠疫情（COVID-19）疫情导致的心理健康危机日益恶化，凸显了对新型疗法的需求，从而刺激了对这一快速发展领域的投资和研究。

比最大的地区

预计北美地区将在预测期内占据最大的市场占有率，主要由美国推动，美国对全球市场的收益贡献巨大。高昂的医疗支出、先进的医疗基础设施以及忧郁症、癫痫和帕金森氏症等神经系统疾病的盛行率不断上升，都使该地区受益。北美的主导地位也归因于顶级公司的存在、优惠的报销政策以及持续的研发计划。此外，推动该地区市场扩张并使其成为全球主要参与者的因素是人们对脑植入及其在治疗长期神经系统疾病方面的有效性的认识不断提高。

复合年增长率最高的地区：

预计亚太地区将在预测期内实现最高的复合年增长率。这得益于神经系统疾病发病率的上升、投资的增加以及医疗基础设施的快速改善。由于人口老化、人们对大脑健康的认识不断提高以及医疗保健服务的便利性，中国、印度和日本等国家对尖端医疗技术的需求日益增长。旨在改善医疗体系的政府计画和投资也在推动市场扩张。此外，由于该地区患者人数众多且可支配收入不断增长，该地区未来成长前景广阔，这也影响了脑植入技术的普及。

免费客製化服务：

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 全面分析其他市场参与者（最多 3 家公司）
    • 主要企业的SWOT分析（最多3家公司）
  • 地理细分
    • 根据客户兴趣对主要国家市场进行估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究资讯来源
    • 初级研究资讯来源
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

第五章 全球脑植入市场（按产品）

  • 深层脑部刺激器
  • 迷走神经刺激
  • 反应性神经刺激

6. 全球脑植入市场（依应用）

  • 慢性疼痛
  • 癫痫
  • 帕金森氏症
  • 忧郁症
  • 阿兹海默症
  • 自发性震颤
  • 其他用途

7. 全球脑植入市场（按最终用户）

  • 医院
  • 神经科诊所
  • 其他最终用户

8. 全球脑植入市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第九章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十章 公司概况

  • Boston Scientific Corporation
  • Medtronic plc
  • Synchron Inc.
  • Abbott Laboratories
  • NeuroPace, Inc.
  • LivaNova Plc
  • Precision Neuroscience Inc
  • NDI Medical LLC
  • Renishaw PLC
  • Aleva Neurotherapeutics SA
  • Beijing PINS Medical Co., Ltd
  • Functional Neuromodulation, Ltd.
  • SceneRay Co., Ltd
  • Cyberonics, Inc.
  • NeuroSigma Inc
Product Code: SMRC29533

According to Stratistics MRC, the Global Brain Implants Market is accounted for $7.40 billion in 2025 and is expected to reach $16.26 billion by 2032 growing at a CAGR of 11.9% during the forecast period. Advanced medical devices known as brain implants, when inserted directly into the brain, facilitate communication with neural tissue. Numerous therapeutic, diagnostic, and enhancement applications exist for these implants. They work by capturing or triggering brain activity, frequently by sending and receiving electrical signals via electrodes. The safety, functionality, and possible uses of brain implants have been greatly enhanced by recent developments in materials science, wireless technology, and machine learning.

According to the American Association of Neurological Surgeons (AANS), approximately 250,000 individuals in the U.S. are affected by dystonia, a neurological movement disorder characterized by involuntary muscle contractions.

Market Dynamics:

Driver:

Increasing neurological disorder prevalence

The prevalence of neurological disorders is rising at a startling rate worldwide. Millions of people worldwide suffer from conditions like epilepsy, Parkinson's disease, Alzheimer's, chronic pain, and depression that don't go away. For example, according to estimates from the World Health Organization (WHO), more than 50 million people worldwide have epilepsy. By controlling aberrant neural activity and enhancing patients' quality of life, brain implants provide an efficient intervention. Moreover, the need for implantable neurostimulation devices is growing since traditional treatments frequently fail, particularly in cases where the patient is drug-resistant.

Restraint:

Expensive procedures and equipment

Deep brain stimulation (DBS) systems and other brain implants are costly; without accounting for surgical and postoperative costs, they can cost anywhere from $35,000 to $50,000 per patient. An important obstacle to access is the high initial and ongoing costs, especially in low- and middle-income nations. Insurance coverage may be restricted, even in developed areas, which deters patients from choosing such treatments. Additionally, the cost burden also affects healthcare systems, particularly when long-term monitoring, device upkeep, and possible issues necessitating adjustments are taken into account.

Opportunity:

Growth of BCIs (brain-computer interfaces)

Brain-computer interfaces (BCIs) are integrating brain implants with external computing systems, opening up revolutionary possibilities in healthcare and other fields. Through the use of brain-computer interfaces (BCIs), people who have lost limbs or are paralyzed can use neural signals to operate computers, wheelchairs, and prosthetic limbs. Initiatives like Synchron's endovascular BCIs and Elon Musk's Neuralink are garnering interest and funding for use in both therapeutic and non-medical fields. Furthermore, the market for brain implants may be greatly expanded outside of traditional medical settings as these technologies develop and find commercial use in communication, gaming, smart devices, and augmented cognition.

Threat:

Ethical backlash and public skepticism

The public is still skeptical of brain implants despite their technological potential because of ethical and philosophical issues. Advocacy groups and patients may find it difficult to accept someone who has mind control, loses autonomy, or changes their personality. In societies where the sanctity of the human brain is highly valued for religious or cultural reasons, invasive procedures are frequently resisted. Moreover, as brain implants start to conflate enhancement and treatment, there is growing discussion about ethical boundaries and possible abuse, which may result in restrictions or prohibitions in some markets.

Covid-19 Impact:

The COVID-19 pandemic affected the market for brain implants in a variety of ways. Initial market disruptions included a temporary drop in implant procedures and clinical trials as a result of supply chain disruptions, hospital capacity reductions, and the postponement of elective neurosurgeries. However, as healthcare systems looked into cutting-edge solutions for remote patient monitoring and chronic disease management, the pandemic also accelerated investments in neuro-technology and digital health. Additionally, long-term market growth is also anticipated due to the increased prevalence of neurological complications linked to prolonged COVID, such as brain fog, stroke, and cognitive dysfunction.

The deep brain stimulator (DBS) segment is expected to be the largest during the forecast period

The deep brain stimulator (DBS) segment is expected to account for the largest market share during the forecast period. DBS is the most widely used neuromodulation therapy, driven by its clinical success and widespread use in treating neurological disorders like Parkinson's disease, essential tremor, dystonia, and obsessive-compulsive disorder. It involves the implantation of electrodes in specific brain regions to deliver controlled electrical impulses, effectively modulating abnormal neural activity. Furthermore, it is FDA-approved, well-established, and supported by a wealth of clinical data, and its adoption is further enhanced by ongoing innovation in device miniaturization, battery life, and MRI compatibility.

The depression segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the depression segment is predicted to witness the highest growth rate, driven by the growing acceptance of neuromodulation therapies and the rising incidence of treatment-resistant depression (TRD). Deep brain stimulation (DBS) and vagus nerve stimulation (VNS) are becoming viable substitutes for traditional antidepressants, which frequently fail to relieve a considerable percentage of patients. Interest in implantable solutions is being fueled by ongoing clinical trials and developments in closed-loop systems designed for mood regulation. Additionally, the COVID-19 pandemic's worsening of the mental health crisis has highlighted the need for novel treatments, spurring investment and research in this rapidly expanding field.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, mostly driven by the United States, which contributes significantly to global market revenue. High healthcare spending, a sophisticated healthcare infrastructure, and an increasing incidence of neurological conditions like depression, epilepsy, and Parkinson's disease all benefit the area. The dominance of North America is also attributed to the existence of top businesses, advantageous reimbursement practices, and ongoing R&D initiatives. Furthermore, driving market expansion in this area and establishing it as a major player globally is growing awareness of brain implants and their effectiveness in treating long-term neurological disorders.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by the rising incidence of neurological disorders, growing investments, and quick improvements in healthcare infrastructure. The need for cutting-edge medical technologies is rising in nations like China, India, and Japan as a result of aging populations, growing awareness of brain health, and easier access to healthcare. Government programs and investments meant to improve healthcare systems also encourage market expansion. Moreover, the region is a very promising market for future growth because of its large patient population and growing disposable incomes, which are also influencing the adoption of brain implant technologies.

Key players in the market

Some of the key players in Brain Implants Market include Boston Scientific Corporation, Medtronic plc, Synchron Inc., Abbott Laboratories, NeuroPace, Inc., LivaNova Plc, Precision Neuroscience Inc, NDI Medical LLC, Renishaw PLC, Aleva Neurotherapeutics SA, Beijing PINS Medical Co., Ltd, Functional Neuromodulation, Ltd., SceneRay Co., Ltd, Cyberonics, Inc. and NeuroSigma Inc.

Key Developments:

In April 2025, Medtronic plc announced a strategic agreement to distribute the advanced Dragonfly(TM)* pancreaticobiliary system from Dragonfly Endoscopy, Inc. in the United States. This innovative platform introduces significant enhancements in pancreaticobiliary endoscopy - a field where procedural standards have remained largely unchanged for decades. Financial terms of the agreement were not disclosed.

In March 2025, Boston Scientific Corporation announced it has entered into a definitive agreement to acquire SoniVie Ltd., a privately held medical device company that has developed the TIVUS(TM) Intravascular Ultrasound System. An investigational technology, the TIVUS system is designed to denervate nerves surrounding blood vessels to treat a variety of hypertensive disorders, including renal artery denervation (RDN) for hypertension.

In December 2024, Abbott Laboratories and DexCom said that they have reached an agreement to settle all patent disputes between them related to continuous glucose monitoring devices. The agreement will dismiss all pending cases in courts and patent offices worldwide, along with a provision preventing legal action between the companies for patent and appearance disputes for the next 10 years.

Products Covered:

  • Deep Brain Stimulator
  • Vagus Nerve Stimulation
  • Responsive Neurostimulation

Applications Covered:

  • Chronic Pain
  • Epilepsy
  • Parkinson's Disease
  • Depression
  • Alzheimer's Disease
  • Essential Tremor
  • Other Applications

End Users Covered:

  • Hospitals
  • Neurology Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Brain Implants Market, By Product

  • 5.1 Introduction
  • 5.2 Deep Brain Stimulator
  • 5.3 Vagus Nerve Stimulation
  • 5.4 Responsive Neurostimulation

6 Global Brain Implants Market, By Application

  • 6.1 Introduction
  • 6.2 Chronic Pain
  • 6.3 Epilepsy
  • 6.4 Parkinson's Disease
  • 6.5 Depression
  • 6.6 Alzheimer's Disease
  • 6.7 Essential Tremor
  • 6.8 Other Applications

7 Global Brain Implants Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Neurology Clinics
  • 7.4 Other End Users

8 Global Brain Implants Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Boston Scientific Corporation
  • 10.2 Medtronic plc
  • 10.3 Synchron Inc.
  • 10.4 Abbott Laboratories
  • 10.5 NeuroPace, Inc.
  • 10.6 LivaNova Plc
  • 10.7 Precision Neuroscience Inc
  • 10.8 NDI Medical LLC
  • 10.9 Renishaw PLC
  • 10.10 Aleva Neurotherapeutics SA
  • 10.11 Beijing PINS Medical Co., Ltd
  • 10.12 Functional Neuromodulation, Ltd.
  • 10.13 SceneRay Co., Ltd
  • 10.14 Cyberonics, Inc.
  • 10.15 NeuroSigma Inc

List of Tables

  • Table 1 Global Brain Implants Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Brain Implants Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Brain Implants Market Outlook, By Deep Brain Stimulator (2024-2032) ($MN)
  • Table 4 Global Brain Implants Market Outlook, By Vagus Nerve Stimulation (2024-2032) ($MN)
  • Table 5 Global Brain Implants Market Outlook, By Responsive Neurostimulation (2024-2032) ($MN)
  • Table 6 Global Brain Implants Market Outlook, By Application (2024-2032) ($MN)
  • Table 7 Global Brain Implants Market Outlook, By Chronic Pain (2024-2032) ($MN)
  • Table 8 Global Brain Implants Market Outlook, By Epilepsy (2024-2032) ($MN)
  • Table 9 Global Brain Implants Market Outlook, By Parkinson's Disease (2024-2032) ($MN)
  • Table 10 Global Brain Implants Market Outlook, By Depression (2024-2032) ($MN)
  • Table 11 Global Brain Implants Market Outlook, By Alzheimer's Disease (2024-2032) ($MN)
  • Table 12 Global Brain Implants Market Outlook, By Essential Tremor (2024-2032) ($MN)
  • Table 13 Global Brain Implants Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 14 Global Brain Implants Market Outlook, By End User (2024-2032) ($MN)
  • Table 15 Global Brain Implants Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 16 Global Brain Implants Market Outlook, By Neurology Clinics (2024-2032) ($MN)
  • Table 17 Global Brain Implants Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 18 North America Brain Implants Market Outlook, By Country (2024-2032) ($MN)
  • Table 19 North America Brain Implants Market Outlook, By Product (2024-2032) ($MN)
  • Table 20 North America Brain Implants Market Outlook, By Deep Brain Stimulator (2024-2032) ($MN)
  • Table 21 North America Brain Implants Market Outlook, By Vagus Nerve Stimulation (2024-2032) ($MN)
  • Table 22 North America Brain Implants Market Outlook, By Responsive Neurostimulation (2024-2032) ($MN)
  • Table 23 North America Brain Implants Market Outlook, By Application (2024-2032) ($MN)
  • Table 24 North America Brain Implants Market Outlook, By Chronic Pain (2024-2032) ($MN)
  • Table 25 North America Brain Implants Market Outlook, By Epilepsy (2024-2032) ($MN)
  • Table 26 North America Brain Implants Market Outlook, By Parkinson's Disease (2024-2032) ($MN)
  • Table 27 North America Brain Implants Market Outlook, By Depression (2024-2032) ($MN)
  • Table 28 North America Brain Implants Market Outlook, By Alzheimer's Disease (2024-2032) ($MN)
  • Table 29 North America Brain Implants Market Outlook, By Essential Tremor (2024-2032) ($MN)
  • Table 30 North America Brain Implants Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 31 North America Brain Implants Market Outlook, By End User (2024-2032) ($MN)
  • Table 32 North America Brain Implants Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 33 North America Brain Implants Market Outlook, By Neurology Clinics (2024-2032) ($MN)
  • Table 34 North America Brain Implants Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 35 Europe Brain Implants Market Outlook, By Country (2024-2032) ($MN)
  • Table 36 Europe Brain Implants Market Outlook, By Product (2024-2032) ($MN)
  • Table 37 Europe Brain Implants Market Outlook, By Deep Brain Stimulator (2024-2032) ($MN)
  • Table 38 Europe Brain Implants Market Outlook, By Vagus Nerve Stimulation (2024-2032) ($MN)
  • Table 39 Europe Brain Implants Market Outlook, By Responsive Neurostimulation (2024-2032) ($MN)
  • Table 40 Europe Brain Implants Market Outlook, By Application (2024-2032) ($MN)
  • Table 41 Europe Brain Implants Market Outlook, By Chronic Pain (2024-2032) ($MN)
  • Table 42 Europe Brain Implants Market Outlook, By Epilepsy (2024-2032) ($MN)
  • Table 43 Europe Brain Implants Market Outlook, By Parkinson's Disease (2024-2032) ($MN)
  • Table 44 Europe Brain Implants Market Outlook, By Depression (2024-2032) ($MN)
  • Table 45 Europe Brain Implants Market Outlook, By Alzheimer's Disease (2024-2032) ($MN)
  • Table 46 Europe Brain Implants Market Outlook, By Essential Tremor (2024-2032) ($MN)
  • Table 47 Europe Brain Implants Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 48 Europe Brain Implants Market Outlook, By End User (2024-2032) ($MN)
  • Table 49 Europe Brain Implants Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 50 Europe Brain Implants Market Outlook, By Neurology Clinics (2024-2032) ($MN)
  • Table 51 Europe Brain Implants Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 52 Asia Pacific Brain Implants Market Outlook, By Country (2024-2032) ($MN)
  • Table 53 Asia Pacific Brain Implants Market Outlook, By Product (2024-2032) ($MN)
  • Table 54 Asia Pacific Brain Implants Market Outlook, By Deep Brain Stimulator (2024-2032) ($MN)
  • Table 55 Asia Pacific Brain Implants Market Outlook, By Vagus Nerve Stimulation (2024-2032) ($MN)
  • Table 56 Asia Pacific Brain Implants Market Outlook, By Responsive Neurostimulation (2024-2032) ($MN)
  • Table 57 Asia Pacific Brain Implants Market Outlook, By Application (2024-2032) ($MN)
  • Table 58 Asia Pacific Brain Implants Market Outlook, By Chronic Pain (2024-2032) ($MN)
  • Table 59 Asia Pacific Brain Implants Market Outlook, By Epilepsy (2024-2032) ($MN)
  • Table 60 Asia Pacific Brain Implants Market Outlook, By Parkinson's Disease (2024-2032) ($MN)
  • Table 61 Asia Pacific Brain Implants Market Outlook, By Depression (2024-2032) ($MN)
  • Table 62 Asia Pacific Brain Implants Market Outlook, By Alzheimer's Disease (2024-2032) ($MN)
  • Table 63 Asia Pacific Brain Implants Market Outlook, By Essential Tremor (2024-2032) ($MN)
  • Table 64 Asia Pacific Brain Implants Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 65 Asia Pacific Brain Implants Market Outlook, By End User (2024-2032) ($MN)
  • Table 66 Asia Pacific Brain Implants Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 67 Asia Pacific Brain Implants Market Outlook, By Neurology Clinics (2024-2032) ($MN)
  • Table 68 Asia Pacific Brain Implants Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 69 South America Brain Implants Market Outlook, By Country (2024-2032) ($MN)
  • Table 70 South America Brain Implants Market Outlook, By Product (2024-2032) ($MN)
  • Table 71 South America Brain Implants Market Outlook, By Deep Brain Stimulator (2024-2032) ($MN)
  • Table 72 South America Brain Implants Market Outlook, By Vagus Nerve Stimulation (2024-2032) ($MN)
  • Table 73 South America Brain Implants Market Outlook, By Responsive Neurostimulation (2024-2032) ($MN)
  • Table 74 South America Brain Implants Market Outlook, By Application (2024-2032) ($MN)
  • Table 75 South America Brain Implants Market Outlook, By Chronic Pain (2024-2032) ($MN)
  • Table 76 South America Brain Implants Market Outlook, By Epilepsy (2024-2032) ($MN)
  • Table 77 South America Brain Implants Market Outlook, By Parkinson's Disease (2024-2032) ($MN)
  • Table 78 South America Brain Implants Market Outlook, By Depression (2024-2032) ($MN)
  • Table 79 South America Brain Implants Market Outlook, By Alzheimer's Disease (2024-2032) ($MN)
  • Table 80 South America Brain Implants Market Outlook, By Essential Tremor (2024-2032) ($MN)
  • Table 81 South America Brain Implants Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 82 South America Brain Implants Market Outlook, By End User (2024-2032) ($MN)
  • Table 83 South America Brain Implants Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 84 South America Brain Implants Market Outlook, By Neurology Clinics (2024-2032) ($MN)
  • Table 85 South America Brain Implants Market Outlook, By Other End Users (2024-2032) ($MN)
  • Table 86 Middle East & Africa Brain Implants Market Outlook, By Country (2024-2032) ($MN)
  • Table 87 Middle East & Africa Brain Implants Market Outlook, By Product (2024-2032) ($MN)
  • Table 88 Middle East & Africa Brain Implants Market Outlook, By Deep Brain Stimulator (2024-2032) ($MN)
  • Table 89 Middle East & Africa Brain Implants Market Outlook, By Vagus Nerve Stimulation (2024-2032) ($MN)
  • Table 90 Middle East & Africa Brain Implants Market Outlook, By Responsive Neurostimulation (2024-2032) ($MN)
  • Table 91 Middle East & Africa Brain Implants Market Outlook, By Application (2024-2032) ($MN)
  • Table 92 Middle East & Africa Brain Implants Market Outlook, By Chronic Pain (2024-2032) ($MN)
  • Table 93 Middle East & Africa Brain Implants Market Outlook, By Epilepsy (2024-2032) ($MN)
  • Table 94 Middle East & Africa Brain Implants Market Outlook, By Parkinson's Disease (2024-2032) ($MN)
  • Table 95 Middle East & Africa Brain Implants Market Outlook, By Depression (2024-2032) ($MN)
  • Table 96 Middle East & Africa Brain Implants Market Outlook, By Alzheimer's Disease (2024-2032) ($MN)
  • Table 97 Middle East & Africa Brain Implants Market Outlook, By Essential Tremor (2024-2032) ($MN)
  • Table 98 Middle East & Africa Brain Implants Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 99 Middle East & Africa Brain Implants Market Outlook, By End User (2024-2032) ($MN)
  • Table 100 Middle East & Africa Brain Implants Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 101 Middle East & Africa Brain Implants Market Outlook, By Neurology Clinics (2024-2032) ($MN)
  • Table 102 Middle East & Africa Brain Implants Market Outlook, By Other End Users (2024-2032) ($MN)